IDEAYA Biosciences, Inc. (IDYA) compared with its closest peers (VNDA, PBYI, LFVN, ANAB, AKBA). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Vanda Pharmaceuticals, Puma Biotechnology, LifeVantage, AnaptysBio, Akebia Therapeutics, Keros Therapeutics, Arcus Biosciences, Rhythm Pharmaceuticals, Schrödinger and Maravai LifeSciences share IDEAYA Biosciences's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Vanda Pharmaceuticals Inc. (VNDA) | $318.12M | -2.4 |
| Puma Biotechnology, Inc. (PBYI) | $476.97M | 17.9 |
| LifeVantage Corporation (LFVN) | $84.02M | 11.6 |
| AnaptysBio, Inc. (ANAB) | $1.68B | -105.4 |
| Akebia Therapeutics, Inc. (AKBA) | $243.63M | -80.3 |
| Keros Therapeutics, Inc. (KROS) | $219.29M | 8.8 |
| Arcus Biosciences, Inc. (RCUS) | $3.82B | -7.2 |
| Rhythm Pharmaceuticals, Inc. (RYTM) | $7.57B | -34.4 |
| Schrödinger, Inc. (SDGR) | $1.46B | -12.7 |
| Maravai LifeSciences Holdings, Inc. (MRVI) | $1.28B | -3.6 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
IDYA overview · IDYA earnings · IDYA financials · IDYA KPIs · IDYA documents · IDYA ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.